Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 4/20 | 0.68 |
| ▸ | MAOB | P27338 | 4/20 | 0.62 |
| ▸ | DRD2 | P14416 | 2/20 | 0.59 |
| ▸ | DRD3 | P35462 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13469516 | 1.00 | HTR1A (0.68) | HTR1AMAOBDRD2DRD3CA12 | |
| SCHEMBL13278990 | 1.00 | HTR1A (0.68) | HTR1AMAOBDRD2DRD3CA12 | |
| SCHEMBL13469501 | 0.91 | CA12 (0.62) | HTR1ACA12CA9 | |
| SCHEMBL13469510 | 0.87 | HTR1A (0.79) | HTR1AMAOBDRD2DRD3 | |
| SCHEMBL4715710 | 0.85 | HTR1A (0.68) | HTR1AMAOBDRD2DRD3 | |
| SCHEMBL14028451 | 0.84 | HTR1A (0.79) | HTR1AMAOBDRD2DRD3 | |
| SCHEMBL10857215 | 0.83 | HTR1A (0.68) | HTR1AMAOBDRD2DRD3 | |
| SCHEMBL1275567 | 0.82 | HTR1A (0.68) | HTR1AMAOBDRD2DRD3 | |
| SCHEMBL7972938 | 0.82 | ALDH1A1 (0.70) | HTR1AMAOBDRD2 | |
| SCHEMBL1532232 | 0.81 | MAOB (0.73) | HTR1AMAOBDRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140154815-A1 | Luminescent Compounds, Complexes and Their Uses | LONDON METROPOLITAN UNIVERSITY (GB) | 2014-06-05 | — | — | US | disclosed |
| WO-2012140437-A1 | LUMINESCENT COMPOUNDS, COMPLEXES AND THEIR USES | LONDON METROPOLITAN UNIVERSITY (GB) | 2012-10-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140154815-A1 | Luminescent Compounds, Complexes and Their Uses | PML, UACA, TBC1D5 | HTR1A 4719/4885MAOB 2457/4885DRD2 4115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.